Your browser doesn't support javascript.
loading
Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease.
Caballero-Camino, Francisco J; Rivilla, Ivan; Herraez, Elisa; Briz, Oscar; Santos-Laso, Alvaro; Izquierdo-Sanchez, Laura; Lee-Law, Pui Y; Rodrigues, Pedro M; Munoz-Garrido, Patricia; Jin, Sujeong; Peixoto, Estanislao; Richard, Seth; Gradilone, Sergio A; Perugorria, Maria J; Esteller, Manel; Bujanda, Luis; Marin, Jose J G; Banales, Jesus M; Cossío, Fernando P.
Afiliación
  • Caballero-Camino FJ; Department of Organic Chemistry I, Center of Innovation in Advanced Chemistry (ORFEO-CINQA), University of the Basque Country/Euskal Herriko Unibertsitatea (UPV/EHU), Donostia International Physics Center (DIPC), Donostia-San Sebastian, Spain.
  • Rivilla I; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain.
  • Herraez E; Department of Organic Chemistry I, Center of Innovation in Advanced Chemistry (ORFEO-CINQA), University of the Basque Country/Euskal Herriko Unibertsitatea (UPV/EHU), Donostia International Physics Center (DIPC), Donostia-San Sebastian, Spain.
  • Briz O; Experimental Hepatology and Drug Targeting (HEVEFARM), Biomedical Research Institute of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain.
  • Santos-Laso A; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.
  • Izquierdo-Sanchez L; Experimental Hepatology and Drug Targeting (HEVEFARM), Biomedical Research Institute of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain.
  • Lee-Law PY; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.
  • Rodrigues PM; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain.
  • Munoz-Garrido P; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain.
  • Jin S; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.
  • Peixoto E; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain.
  • Richard S; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain.
  • Gradilone SA; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, UPV/EHU, Donostia-San Sebastian, Spain.
  • Perugorria MJ; The Hormel Institute, University of Minnesota, Austin, MN.
  • Esteller M; Masonic Cancer Center, University of Minnesota, Minneapolis, MN.
  • Bujanda L; The Hormel Institute, University of Minnesota, Austin, MN.
  • Marin JJG; Masonic Cancer Center, University of Minnesota, Minneapolis, MN.
  • Banales JM; The Hormel Institute, University of Minnesota, Austin, MN.
  • Cossío FP; Masonic Cancer Center, University of Minnesota, Minneapolis, MN.
Hepatology ; 73(1): 186-203, 2021 01.
Article en En | MEDLINE | ID: mdl-32145077

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Ácido Ursodesoxicólico / Apoptosis / Quistes / Drogas Sintéticas / Hígado / Hepatopatías Límite: Animals Idioma: En Revista: Hepatology Año: 2021 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Ácido Ursodesoxicólico / Apoptosis / Quistes / Drogas Sintéticas / Hígado / Hepatopatías Límite: Animals Idioma: En Revista: Hepatology Año: 2021 Tipo del documento: Article País de afiliación: España